Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dana Pizzuti Insider Profile
4 Followers
Dana Pizzuti, Chief Med and Dev Officer at Crinetics Pharmaceuticals, holds 28.51K shares in Crinetics Pharmaceuticals (Ticker: CRNX).
Dana Pizzuti Crinetics Pharmaceuticals (CRNX)Chief Med and Dev Officer
Crinetics Pharmaceuticals (CRNX)
Chief Med and Dev Officer
Ranked #92,974 out of 98,042 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-70.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Med and Dev Officer
Roles that Dana Pizzuti holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 25, 2024 - Today
Return:-17.30%
The most profitable trade made by Dana Pizzuti
Dana Pizzuti's Trading History
List of latest transactions for each holding click on a transaction to see Dana Pizzuti's performance on stock
You May Also Like
Dana Pizzuti insider profile FAQ
What is the percentage of profitable transactions made by Dana Pizzuti?
The percentage of profitable transactions made by Dana Pizzuti is 0%.
What is the average return per transaction made by Dana Pizzuti?
The average return per transaction made by Dana Pizzuti is -70.10%.
What stocks does Dana Pizzuti hold?
Dana Pizzuti holds: CRNX stocks.
What was Dana Pizzuti’s latest transaction?
Dana Pizzuti latest transaction was an Uninformative Buy of $242.79K.
What was Dana Pizzuti's most profitable transaction?
Dana Pizzuti’s most profitable transaction was an Informative Sell of CRNX stock on June 25, 2024. The return on the trade was -17.30%.
What is Dana Pizzuti's role in Crinetics Pharmaceuticals?
Dana Pizzuti's role in Crinetics Pharmaceuticals is Chief Med and Dev Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.